Eva Ehlich

Partner at Maiwald Intellectual Property
Ranked in Defensive patent aggregation, IP management consultancy
IAM Research

The IAM Strategy 300 focuses exclusively on patent practitioners and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

IAM Says

“An extremely safe pair of hands for complex IP issues and top-level portfolio strategy in the pharmaceutical and biotechnology space, Eva Ehlich is commercially and culturally astute and easily grapples with the complexities and politics of larger international projects.”

Eva Ehlich's Profile

Eva Ehlich is a partner and managing director at Maiwald. She is an internationally well-known and esteemed German and European patent attorney focused on overall IP strategies, including drafting applications, building and prosecuting large worldwide portfolios, enforcing and defending patents, as well as establishing and implementing freedom-to-operate strategies. She has also passed the US patent agent examination and has global prosecution experience, which allows her to advise on global strategies, particularly in the areas of drug delivery, pharmaceuticals and medical uses (small molecules and biologics).

Ms Ehlich has been honoured several times and has been listed as an IP Star by Managing International Property. She has been recommended as Germany’s Best Lawyer by Handelsblatt and as a Frequently Recommended Lawyer by JUVELegal 500 Germany and Legal 500 EMEA, which in 2020 said that Ms Ehlich “stands out due to the rare ability, to combine thoroughness and pragmatism. She delivers excellent results”. In 2020, she was also among the top 1000 World’s Leading Patent Professionals by IAM.

Over the past 15 years, Ms Ehlich has built a very stable group of attorneys that continually work with her. She takes particular pride in encouraging and promoting female attorneys.

Unlock unlimited access to all IAM content